Cargando…
Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic?
A new variant named Omicron (B.1.1.529), first identified in South Africa, has become of considerable interest to the World Health Organization. This variant differs from the other known major variants, as it carries a large number of unusual mutations, particularly in the spinous process protein an...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962637/ https://www.ncbi.nlm.nih.gov/pubmed/35349754 http://dx.doi.org/10.1002/iid3.606 |
_version_ | 1784677844114210816 |
---|---|
author | Ding, Kaixi Jiang, Wei Xiong, Chunping Lei, Ming |
author_facet | Ding, Kaixi Jiang, Wei Xiong, Chunping Lei, Ming |
author_sort | Ding, Kaixi |
collection | PubMed |
description | A new variant named Omicron (B.1.1.529), first identified in South Africa, has become of considerable interest to the World Health Organization. This variant differs from the other known major variants, as it carries a large number of unusual mutations, particularly in the spinous process protein and receptor binding domains. Some specific mutation sites make it vaccine resistant, highly infectious, and highly pathogenic. The world fears that the Omicron variant could be even more harmful than the previous major variant, given that it has emerged amid fierce competition to trigger a new global pandemic peak as infections in South Africa rise. However, some epidemiological evidence has emerged that the Omicron variant may produce milder patient symptoms. We speculate if the virulence of the Omicron variant will diminish as transmissibility increases, thereby signaling the beginning of the end for the global COVID‐19 pandemic. Based on this view, we make recommendations for COVID‐19 mitigation in the present and future. However, it will take a few weeks to determine the true threat posed by the Omicron variant and we need to be fully prepared for future outbreaks, regardless of their severity. |
format | Online Article Text |
id | pubmed-8962637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89626372022-04-04 Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic? Ding, Kaixi Jiang, Wei Xiong, Chunping Lei, Ming Immun Inflamm Dis Review Articles A new variant named Omicron (B.1.1.529), first identified in South Africa, has become of considerable interest to the World Health Organization. This variant differs from the other known major variants, as it carries a large number of unusual mutations, particularly in the spinous process protein and receptor binding domains. Some specific mutation sites make it vaccine resistant, highly infectious, and highly pathogenic. The world fears that the Omicron variant could be even more harmful than the previous major variant, given that it has emerged amid fierce competition to trigger a new global pandemic peak as infections in South Africa rise. However, some epidemiological evidence has emerged that the Omicron variant may produce milder patient symptoms. We speculate if the virulence of the Omicron variant will diminish as transmissibility increases, thereby signaling the beginning of the end for the global COVID‐19 pandemic. Based on this view, we make recommendations for COVID‐19 mitigation in the present and future. However, it will take a few weeks to determine the true threat posed by the Omicron variant and we need to be fully prepared for future outbreaks, regardless of their severity. John Wiley and Sons Inc. 2022-03-29 /pmc/articles/PMC8962637/ /pubmed/35349754 http://dx.doi.org/10.1002/iid3.606 Text en © 2022 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Articles Ding, Kaixi Jiang, Wei Xiong, Chunping Lei, Ming Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic? |
title | Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic? |
title_full | Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic? |
title_fullStr | Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic? |
title_full_unstemmed | Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic? |
title_short | Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic? |
title_sort | turning point: a new global covid‐19 wave or a signal of the beginning of the end of the global covid‐19 pandemic? |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962637/ https://www.ncbi.nlm.nih.gov/pubmed/35349754 http://dx.doi.org/10.1002/iid3.606 |
work_keys_str_mv | AT dingkaixi turningpointanewglobalcovid19waveorasignalofthebeginningoftheendoftheglobalcovid19pandemic AT jiangwei turningpointanewglobalcovid19waveorasignalofthebeginningoftheendoftheglobalcovid19pandemic AT xiongchunping turningpointanewglobalcovid19waveorasignalofthebeginningoftheendoftheglobalcovid19pandemic AT leiming turningpointanewglobalcovid19waveorasignalofthebeginningoftheendoftheglobalcovid19pandemic |